FLC testing in monoclonal gammopathies

Giampaolo Merlini
 |  Sat Aug 01 00:00:00 CEST 2015

Learn how the free light chain (FLC) assay has revolutionized the care of diseases caused by the systemic proteotoxic effect exerted by light chains, such as AL amyloidosis, light chain deposition disease, and monoclonal gammopathies of renal significance.


Share this page: